Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: Studies in patients with chronic progressive multiple sclerosis-Reference-Cited by-同舟云学术

Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: Studies in patients with chronic progressive multiple sclerosis

Published:1991-01 Issue:5 Volume:13 Page:455-461
ISSN:0192-0561
Container-title:International Journal of Immunopharmacology
language:en
Short-container-title:International Journal of Immunopharmacology

Author:

Chiappelli F.,Myers L.W.,Ellison G.W.,Liao D.,Fahey J.L.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology

Reference20 articles.

1. Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus;Epstein;Arthritis Rheum.,1974

2. Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow-up of 110 patients for 2–6 years;Gonsette;J. Neurol.,1977

3. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange and ACTH;Hauser;New Engl. J. Med.,1983

4. Treatment of chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone;Hommes;Clin. Neurol. Neurosurg.,1975

5. Overview of the rationale for immunomodulating therapies in multiple sclerosis;Lisak;Neurology,1988

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular immune correlates of clinical severity in oral lichen planus: preliminary association with mood states;Oral Diseases;2008-06-28

2. A Double-Blind, Placebo-Controlled, Randomized Trial of Cladribine in Relpaasing-Remitting Multiple Sclerosis;Proceedings of the Association of American Physicians;1999-01

3. Immunosuppressive Agents;Lupus;1999

4. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders.;American Journal of Respiratory and Critical Care Medicine;1997-02

5. The immune profile of multiple sclerosis: T-lymphocyte effects predominate over all other factors in cyclophosphamide-treated patients;Journal of Neuroimmunology;1995-12